Progressive failure of coronary flow during reperfusion of myocardial infarction: Documentation of the no reflow phenomenon with positron emission tomography

Journal of the American College of Cardiology

Volumn 16, Issue 3, 1990, Pages 695-704

  Jeremy, Richmond W ^a   Links, Jonathan M ^a   Becker, Lewis C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; RUBIDIUM 82;

ANIMAL EXPERIMENT; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY REPERFUSION; DOG; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; CORONARY CIRCULATION; DOGS; HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RUBIDIUM RADIOISOTOPES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0024992171     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(90)90362-S     Document Type: Article

References (48)

1. A prospective trial of Intravenous Streptokinase in Acute Myocardial Infarction (ISAM) mortality morbidity and infarct size at 21 days
2. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side effects from 33 randomized controlled trials
3. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction
4. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival
5. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
6. Western Washington randomised trial of intracoronary streptokinase in acute myocardial infarction
7. Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate
8. Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction: a randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator
9. Blood supply to the myocardium after temporary coronary occlusion
10. The “no-reflow” phenomenon after temporary coronary occlusion in the dog
11. Compromized microvascular integrity in ischemic myocardium
12. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?
13. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow
14. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog
15. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs
16. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury
17. Blood flow measurements with radionuclide labelled particles
18. A precision flow-controlled rubidium-82 generator for bolus or constant infusion studies of the heart and brain
19. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82
20. Early phase acute myocardial infarct size quantification: validation of the triphenyl-tetrazolium chloride tissue enzyme staining technique
21. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia: evidence for neutrophil-mediated reperfusion injury
22. The loss of radioactive microspheres from canine necrotic myocardium
23. Local effects of acute cellular injury on regional myocardial blood flow
24. Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog
25. Recovery of left ventricular segmental function after long-term reperfusion following temporary coronary occlusion in conscious dogs: comparison of 2- and 4-hour occlusions
26. Effects of coronary artery reperfusion on regional myocardial blood flow and function in conscious baboons
27. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors
28. Differences in thallium-201 uptake in reperfused and non-reperfused myocardial infarction
29. Kinetics of rubidium-82 after coronary occlusion and reperfusion
30. Cardiac emission computed tomography underestimation of regional tracer concentrations due to wall motion abnormalities
31. The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography after coronary thrombolysis
32. Studies of experimental coronary artery reperfusion: effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage
33. Ventricular contracture and compliance changes with global ischemia and reperfusion, and their effect on coronary resistance in the rat
34. Platelet deposition after surgically induced myocardial ischemia
35. Accumulation of polymorphonuclear leukocytes during 3 hours experimental myocardial ischemia
36. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation
37. Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion
38. Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion
39. Positron emission tomography: assessment of myocardial blood flow and metabolism
40. Regional assessment of myocardial metabolic integrity in vivo by positron emission tomography with 11-C-labeled palmitate
41. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18-F labeled fluorodeoxyglucose and N-13 ammonia
42. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model
43. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium defects
44. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography
45. Assessment of thallium-201 redistribution versus glucose uptake as predictors of viability after coronary occlusion and reperfusion
46. Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase
47. Beneficial effect of residual antegrade flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction